Lawrence Wilson

Surprise bills, unexplained charges, and a lack of price transparency adds stress to patients’ recoveries and makes some leery of seeking further care.

Securities and Exchange Commission records, earnings calls, and public statements show the term and scope of most favored nation deals.

Despite persistent effort from both major parties, disagreement continues over the role of government in providing health care.

Patients may be charged more than 2,000 percent more for the same drug at the same hospital. Researchers say price transparency is the key to change.

The president listed key aims of his Great Healthcare Plan in his State of the Union speech, asking House and Senate leaders to take action.

A judge’s ruling that some payments to insurers were illegal set off a cost spiral.

A hearing by a House panel focused on pharmacy benefit managers.

The new regulations, once finalized, will strengthen eligibility verification, prohibit misleading marketing practices, and track improper payments.

Health care spending reached new heights in 2024 and continues to grow as a share of the U.S. economy, placing an increasing burden on consumers.

The changes apply to pharmacy benefit managers—the middlemen in the pharmacy business—but experts are unsure how much drug prices will come down.

Surprise bills, unexplained charges, and a lack of price transparency adds stress to patients’ recoveries and makes some leery of seeking further care.

Securities and Exchange Commission records, earnings calls, and public statements show the term and scope of most favored nation deals.

Despite persistent effort from both major parties, disagreement continues over the role of government in providing health care.

Patients may be charged more than 2,000 percent more for the same drug at the same hospital. Researchers say price transparency is the key to change.

The president listed key aims of his Great Healthcare Plan in his State of the Union speech, asking House and Senate leaders to take action.

A judge’s ruling that some payments to insurers were illegal set off a cost spiral.

A hearing by a House panel focused on pharmacy benefit managers.

The new regulations, once finalized, will strengthen eligibility verification, prohibit misleading marketing practices, and track improper payments.

Health care spending reached new heights in 2024 and continues to grow as a share of the U.S. economy, placing an increasing burden on consumers.

The changes apply to pharmacy benefit managers—the middlemen in the pharmacy business—but experts are unsure how much drug prices will come down.